Bridging Obesity and MASLD Through Metabolic Dysfunction (Non-CME)

Name: Bridging Obesity and MASLD Through Metabolic Dysfunction (Non-CME)
Start: 2026-11-15T11:45:00-05:00
End: 2026-11-15T13:15:00-05:00

Industry programs may be promotional activities and are not approved for CME/CE credit unless indicated. The editorial style and content of the below information, as well as the opinions expressed by presenters, are those of the sponsor or presenter and are not supported, endorsed, or accredited by The Obesity Society.

Corporate-Supported Symposium (Non-CME)

VIEW MORE FEATURED INDUSTRY EVENTS >

Details

November 15 @ 11:45 am — 1:15 pm ET

Riverview Ballroom A

Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.

Speakers

Presenter
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital
Professor of Medicine
Summit and Pinnacle Clinical Research
Chief Scientific Officer and Co-Chairman of the Board
Houston, TX

Presenter
Michelle Look, MD, FAAFP, DABOM
knownwell
Medical Director Clinical Research, Obesity Medicine and Sports Medicine Physician
San Diego, CA

Program Description

This program will explore the interconnected relationships between obesity, metabolic dysfunction, and MASLD/MASH, highlighting the role of visceral and hepatic fat in amplifying metabolic dysfunction. Participants will learn why waist circumference–based measures and earlier liver assessment, including FIB-4, should be considered integral components of obesity care. Participants will also examine the importance of individualized, comprehensive care plans that address the diverse needs of people living with obesity.